ArticleBMC endocrine disorders2024

First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.

Dominik Soll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.